Romosozumab Suppliers & Bulk Manufacturers
Available Forms: injection (prefilled syringe)
Available Strengths: 105 mg/1.17 mL
Reference Brands: Evenity (USA/EU)
Category: Osteoporosis
Romosozumab is a monoclonal antibody used for the treatment of osteoporosis in postmenopausal women and men at high risk of fracture. It works by inhibiting the protein sclerostin, which increases bone formation and decreases bone resorption. Romosozumab is administered as a monthly subcutaneous injection and helps improve bone density and reduce fracture risk. Romosozumab is available in injection (prefilled syringe) and strengths such as 105 mg/1.17 mL. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Romosozumab is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Romosozumab can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Romosozumab is used to treat osteoporosis in postmenopausal women and men at high risk of fracture.
Romosozumab is made from a humanized monoclonal antibody that binds to and inhibits sclerostin, a protein that limits bone formation.
The trade name of Romosozumab is Evenity.
Romosozumab is made by Amgen Inc. and UCB Pharma.
The generic name of the product is Romosozumab.
The brand name of Romosozumab is Evenity.
Romosozumab is manufactured by Amgen Inc. in the United States and also by UCB Pharma in Belgium.
Related Products
Risedronate Sodium
Strength:
5 mg, 30 mg, 35 mg, 75 mg, 150 mg
Form: Tablets
Reference Brands: Actonel (USA)
View Details
Ibandronate Sodium
Strength:
150 mg
Form: Tablets
Reference Brands: Boniva (USA), Iasibon (EU)
View Details
Diacerein
Strength:
50 mg
Form: Capsules
Reference Brands: Art 50 mg (EU), Arthrofar (EU)
View Details
Denosumab
Strength:
60 mg/mL, 120 mg/1.7 mL
Form: Injection
Reference Brands: Prolia, Xgeva
View DetailsQuick Response Guaranteed | Verified Suppliers
